Mycophenolate Mofetil Tablet, Film Coated
Product Images NDC 59651-638

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mycophenolate Mofetil (NDC 59651-638). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mycophenolate-fig1 (Mycophenolate Fig1)

Mycophenolate-fig1 (Mycophenolate Fig1)
This is a description of Mycophenolate Mofetil Tablets, USP which contain 500 mg of Mycophenolate Mofetil USP per tablet. The usual dosage information and important prescribing details should be read from the accompanying insert. The medication guide should be dispensed to each patient separately. The tablets should be stored in a tight, light-resistant container at 20° to 25°C (68° to 77°F) with excursions permitted to 15° to 30°C (59° to 86°F). For more information, medication guides can be printed from the website provided. The tablets are distributed by Aurobindo Pharma USA, Inc. and are made in India.*
FDA Label Image

Mycophenolate-str (Mycophenolate Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.